Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 2,156 | 2,773 | 4,297 | 4,475 | 5,559 |
| Operating Income | -2,156 | -2,773 | -4,297 | -4,475 | -5,559 |
| Interest Expense | 3 | 3 | 0 | 2 | 2 |
| Other Income | 43 | 41 | 39 | 44 | 39 |
| Pre-tax Income | -2,116 | -2,735 | -4,258 | -4,433 | -5,522 |
| Net Income Continuous | -2,116 | -2,735 | -4,197 | -4,433 | -5,522 |
| Net Income | $-2,116 | $-2,735 | $-4,197 | $-4,433 | $-5,522 |
| EPS Basic Total Ops | -32.89 | -43.34 | -66.93 | -84.21 | -127.39 |
| EPS Basic Continuous Ops | -32.82 | -43.39 | -68.66 | -83.21 | -127.86 |
| EPS Diluted Total Ops | -32.89 | -43.34 | -66.93 | -84.21 | -127.39 |
| EPS Diluted Continuous Ops | -32.82 | -43.39 | -68.66 | -83.21 | -127.86 |
| EBITDA(a) | $-2,151 | $-2,765 | $-4,221 | $-4,360 | $-5,427 |